Last update 09 Dec 2024

Rimiducid

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Rimiducid (USAN/INN), AP-1903
Target
Mechanism
FKBP12 (FK506-binding protein 1A ligand)
Originator Organization
Inactive Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Structure

Molecular FormulaC78H98N4O20
InChIKeyGQLCLPLEEOUJQC-ZTQDTCGGSA-N
CAS Registry195514-63-7

External Link

KEGGWikiATCDrug Bank
D11195--

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Graft vs Host DiseasePhase 2
US
27 Dec 2013
LeukemiaPhase 2
US
27 Dec 2013
Multiple MyelomaPhase 2
US
27 Dec 2013
Myelodysplastic SyndromesPhase 2
US
27 Dec 2013
B lymphoblastic leukemia lymphomaPhase 2
US
-
Congenital Bone Marrow Failure SyndromesPhase 1
US
01 Feb 2015
HemoglobinopathiesPhase 1
US
01 Feb 2015
Lymphohistiocytosis, HemophagocyticPhase 1
US
01 Feb 2015
Metabolic DiseasesPhase 1
US
01 Feb 2015
Primary Immunodeficiency DiseasesPhase 1
US
01 Feb 2015
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
1
yzvdkvlxdf(jouqztcqfi) = cxqlujsdrk wllqdwapoz (dmvsvwodwm, ujrzkaqzbe - zambxvoqyv)
-
25 Mar 2024
Phase 1
7
olsoycheai(skajylkkdo) = wxycytlnas euumpimehx (yzlancstzl )
Positive
21 Feb 2023
Phase 1
13
Anti-Signaling lymphocytic activation molecule F7 (SLAMF7) - Chimeric antigen receptor (CAR) + T cells
(LEVEL 1 - 0.66x10^6 Per Kilogram (kg))
fofipsxroo(jsdbxbhmln) = ckklcezdac nzztlahemc (ndapgeunwc, jvtuvjupxo - liuetyupcb)
-
09 Sep 2021
Anti-Signaling lymphocytic activation molecule F7 (SLAMF7) - Chimeric antigen receptor (CAR) + T cells
(LEVEL 2 - 2.0x10^6 Per kg)
fofipsxroo(jsdbxbhmln) = nzjuaujjeh nzztlahemc (ndapgeunwc, gdyjxmshxy - clclqryqih)
Phase 2
-
wwmoetpxmy(zmixlylqqg) = yozidzojpl hpwtyxrsxh (nvhngzxrdd, 84.8 - 94.6)
Positive
08 Jul 2019
Not Applicable
-
-
ommimtgtfj(ssjicsaaur) = kbcbnpimco tqajoslagt (codavtpuzh )
-
01 May 2013
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free